---
title: "Double Medical released its first-quarter performance, with a net profit attributable to the parent company of 103 million yuan, an increase of 67.04%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/238115126.md"
description: "According to the Zhitong Finance APP, Double Medical released its first-quarter report for 2025, with operating revenue of 550 million yuan, a year-on-year increase of 28.80%. The net profit attributable to shareholders of the listed company was 103 million yuan, a year-on-year increase of 67.04%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 97.1211 million yuan, a year-on-year increase of 96.76%. The basic earnings per share were 0.25 yuan"
datetime: "2025-04-29T15:55:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238115126.md)
  - [en](https://longbridge.com/en/news/238115126.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238115126.md)
generator: "portal-rs"
---

# Double Medical released its first-quarter performance, with a net profit attributable to the parent company of 103 million yuan, an increase of 67.04%

According to the Zhitong Finance APP, Double Medical (002901.SZ) released its first-quarter report for 2025, showing an operating income of 550 million yuan, a year-on-year increase of 28.80%. The net profit attributable to shareholders of the listed company was 103 million yuan, a year-on-year increase of 67.04%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 97.1211 million yuan, a year-on-year increase of 96.76%. The basic earnings per share were 0.25 yuan

### Related Stocks

- [002901.CN](https://longbridge.com/en/quote/002901.CN.md)

## Related News & Research

- [$860 Billion Stuck: Private Equity’s Zombie Problem Deepens](https://longbridge.com/en/news/296389093.md)
- [10:35 ETThe 14th Annual Globee® Awards for Leadership Invite Local Workplace and Business Achievement Nominations Worldwide](https://longbridge.com/en/news/296371082.md)
- [11:06 ETEndurance Named to Inc. 5000 for 11th Time, Continuing National Growth](https://longbridge.com/en/news/296124358.md)
- [Moving at the speed of pharma digitalisation: driving ROI from AI and digital tools](https://longbridge.com/en/news/296126091.md)
- [Flexdeal chair Alberto Amaral buys EUR 150,000 in shares](https://longbridge.com/en/news/296250174.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**